The alliance between, Carl Zeiss Meditec and IntraOp for marketing of GMV’s intraoperative radiation therapy planner becomes stronger year by year. Specialists are now exploring application of this inhouse GMV technology to new treatments. These breakthroughs have been on show at the 38th congress of the European Society for Radiotherapy and Oncology (ESTRO). Carl Zeiss Meditec, in particular, showed the advantages of the use of Intrabeam and radiance in the treatment of glioblastoma, an especially aggressive brain tumor, and also in bone metastasis in the vertebrae, after due testing by collaborating clinicians. IntraOp, for its part, showed the benefits of administering IORT together with its solution based on a linear electron accelerator, MOBETRON, top-quality intraoperative imaging equipment and radiance.

In the words of Carlos Illana, head of the radiance product, “this congress is presenting the latest breakthroughs at world level. And from everything we’ve learned along the way, two of the most important aspects are, firstly, the trend of applying Deep Learning technology in radiation oncology research, especially for automated segmentation tasks, cutting down the volume contouring time, and, secondly, the growing takeup of very high-dose flash therapy, which acts directly on the tumorous tissue, saving healthy tissue from any harm ".